BSE Live
Apr 02, 16:01Prev. Close
69.67
Open Price
74.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Relic Life Science (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -4.77 | -2.42 | 0.53 | 1.38 | 1.11 | |
| Diluted EPS (Rs.) | -4.77 | -2.42 | 0.53 | 1.38 | 1.11 | |
| Cash EPS (Rs.) | -4.19 | -1.97 | 0.99 | 1.49 | 1.24 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 10.57 | 15.54 | 17.95 | 17.42 | 16.03 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 10.57 | 15.54 | 17.95 | 17.42 | 16.03 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 4.62 | 4.26 | 4.04 | 4.79 | 3.63 | |
| PBDIT/Share (Rs.) | -4.06 | -1.89 | 1.28 | 1.83 | 1.47 | |
| PBIT/Share (Rs.) | -4.65 | -2.40 | 0.93 | 1.55 | 1.31 | |
| PBT/Share (Rs.) | -4.73 | -2.46 | 0.93 | 1.54 | 1.31 | |
| Net Profit/Share (Rs.) | -4.77 | -2.48 | 0.64 | 1.21 | 1.08 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -87.83 | -44.40 | 31.77 | 38.26 | 40.55 | |
| PBIT Margin (%) | -100.58 | -56.34 | 23.08 | 32.33 | 36.13 | |
| PBT Margin (%) | -102.29 | -57.83 | 23.07 | 32.26 | 35.97 | |
| Net Profit Margin (%) | -103.33 | -58.20 | 15.71 | 25.19 | 29.72 | |
| Return on Networth / Equity (%) | -45.15 | -15.95 | 3.53 | 6.92 | 6.72 | |
| Return on Capital Employed (%) | -16.68 | -14.54 | 5.19 | 8.96 | 8.17 | |
| Return on Assets (%) | -16.96 | -14.66 | 3.38 | 6.77 | 6.46 | |
| Total Debt/Equity (X) | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.21 | 0.24 | 0.22 | 0.28 | 21.76 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 96.24 | 27.52 | 16.13 | 24.42 | 18.59 | |
| Quick Ratio (X) | 96.24 | 27.52 | 16.13 | 24.42 | 18.59 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 18.47 | 2.58 | 2.90 | 4.24 | 2.22 | |
| EV/Net Operating Revenue (X) | 11.11 | 1.69 | 2.00 | 2.46 | 1.70 | |
| EV/EBITDA (X) | -12.64 | -3.80 | 6.28 | 6.43 | 4.20 | |
| MarketCap/Net Operating Revenue (X) | 15.50 | 3.52 | 4.46 | 4.38 | 3.85 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 6.77 | 0.97 | 1.00 | 1.20 | 0.87 | |
| Price/Net Operating Revenue | 15.50 | 3.52 | 4.46 | 4.38 | 3.85 | |
| Earnings Yield | -0.07 | -0.17 | 0.04 | 0.06 | 0.08 |
14.11.2025
Relic Life Scie Consolidated September 2025 Net Sales at Rs 0.60 crore, down 5.44% Y-o-Y
29.07.2025
Relic Life Scie Consolidated June 2025 Net Sales at Rs 1.28 crore, up 214.94% Y-o-Y
03.06.2025
Relic Life Scie Consolidated March 2025 Net Sales at Rs 0.47 crore, up 22.43% Y-o-Y
28.05.2025
Relic Life Scie Standalone March 2025 Net Sales at Rs 0.16 crore, down 59.42% Y-o-Y
14.11.2025
Relic Life Scie Consolidated September 2025 Net Sales at Rs 0.60 crore, down 5.44% Y-o-Y
29.07.2025
Relic Life Scie Consolidated June 2025 Net Sales at Rs 1.28 crore, up 214.94% Y-o-Y
03.06.2025
Relic Life Scie Consolidated March 2025 Net Sales at Rs 0.47 crore, up 22.43% Y-o-Y
28.05.2025
Relic Life Scie Standalone March 2025 Net Sales at Rs 0.16 crore, down 59.42% Y-o-Y
28.05.2024
28.05.2024
Bulk deals: Kotak Mahindra MF buys 3.86% in Prudent Corporate Advisory Services
27.05.2024
29.04.2024
Buy UTI Asset Management Company; target of Rs 1050: Prabhudas Lilladher